The analyses shows that high PAR1 expression was associated with a mesenchymal cancer signature, as well as with a hallmark epithelial-to-mesenchymal transition signature in all expression sets analyzed, including a micro-dissected tumor cell set. The gene discussed is F2R; the disease is neoplasm.